Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Nishiguchi

Showing results (281-290 of 303) with videos related to

Pageof 31
Sort By:
Journal of Gastroenterology|June 17, 2016
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective studyTakashi Taida, Makoto Arai, Tatsuo Kanda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 19, 2019
Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseasesTakashi Nishimura, Hiroko Iijima, Hiroki Nishikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 17, 2015
Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studiesTakeshi Okanoue, Toshihide Shima, Chitomi Hasebe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 4, 2013
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatmentTomoyuki Takashima, Hirayuki Enomoto, Toshiaki Ninomiya, et al.
Journal of Gastroenterology|September 12, 2018
Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trialTetsuo Takehara, Naoya Sakamoto, Shuhei Nishiguchi, et al.
Journal of Gastroenterology|April 15, 2014
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled studyKiwamu Okita, Namiki Izumi, Osamu Matsui, et al.
Plos One|October 11, 2016
Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis CKayoko Matsunami, Nao Nishida, Naoko Kaneko, et al.
Journal of Gastroenterology|September 12, 2014
Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trialKiwamu Okita, Namiki Izumi, Kenji Ikeda, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2013
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in JapanAkira Sato, Michio Sata, Kenji Ikeda, et al.
Ultrasound in Medicine & Biology|July 7, 2019
Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic SteatosisToshifumi Tada, Hiroko Iijima, Natsuko Kobayashi, et al.
Pageof 31

Showing results (281-290 of 303) with videos related to

Sort By:
Pageof 31
Journal of Gastroenterology|June 17, 2016
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective studyTakashi Taida, Makoto Arai, Tatsuo Kanda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 19, 2019
Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseasesTakashi Nishimura, Hiroko Iijima, Hiroki Nishikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 17, 2015
Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studiesTakeshi Okanoue, Toshihide Shima, Chitomi Hasebe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 4, 2013
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatmentTomoyuki Takashima, Hirayuki Enomoto, Toshiaki Ninomiya, et al.
Journal of Gastroenterology|September 12, 2018
Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trialTetsuo Takehara, Naoya Sakamoto, Shuhei Nishiguchi, et al.
Journal of Gastroenterology|April 15, 2014
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled studyKiwamu Okita, Namiki Izumi, Osamu Matsui, et al.
Plos One|October 11, 2016
Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis CKayoko Matsunami, Nao Nishida, Naoko Kaneko, et al.
Journal of Gastroenterology|September 12, 2014
Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trialKiwamu Okita, Namiki Izumi, Kenji Ikeda, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2013
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in JapanAkira Sato, Michio Sata, Kenji Ikeda, et al.
Ultrasound in Medicine & Biology|July 7, 2019
Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic SteatosisToshifumi Tada, Hiroko Iijima, Natsuko Kobayashi, et al.
Pageof 31